ABSTRACT
Hemochorial placentation involves the differentiation of invasive trophoblast cells, specialized cells that possess the capacity to exit the placenta and invade into the uterus where they restructure the vasculature. Invasive trophoblast cells arise from a well-defined compartment within the placenta, referred to as the junctional zone in rat and the extravillous trophoblast cell column in human. In this study, we investigated roles for AKT1, a serine/threonine kinase, in placental development using a genome-edited/loss-of-function rat model. Disruption of AKT1 resulted in placental, fetal and postnatal growth restriction. Forkhead box O4 (Foxo4), which encodes a transcription factor and known AKT substrate, was abundantly expressed in the junctional zone and in invasive trophoblast cells of the rat placentation site. Foxo4 gene disruption using genome editing resulted in placentomegaly, including an enlarged junctional zone. AKT1 and FOXO4 regulate the expression of many of the same transcripts expressed by trophoblast cells, but in opposite directions. In summary, we have identified AKT1 and FOXO4 as part of a regulatory network that reciprocally controls critical indices of hemochorial placenta development.
INTRODUCTION
The placenta is an extra-embryonic structure essential for normal fetal development (Maltepe and Fisher, 2015; Burton et al., 2016). Placentas have two main functions: (1) transformation of the maternal environment to support viviparity and (2) regulation of the transfer of nutrients to the fetus (Soares et al., 2018; Knöfler et al., 2019). These specialized functions are ascribed to trophoblast cells, which differentiate along a multi-lineage pathway and are situated within specific compartments of the placenta (Gardner and Beddington, 1988; Soares et al., 2018; Knöfler et al., 2019; Aplin and Jones, 2021). Placentas of different species vary with respect to shape, size and connectivity to the mother (Wooding and Burton, 2008; Roberts et al., 2016). Placentation in some mammalian species is characterized by trophoblast cells migrating into the maternal uterus where they modify the vasculature facilitating maternal nutrient flow to the placenta (Pijnenborg et al., 1981; Soares et al., 2018). This type of placenta is referred to as hemochorial (Wooding and Burton, 2008; Roberts et al., 2012). In human and rat, hemochorial placentation occurs whereby invasive trophoblast cells migrate deep into the uterine parenchyma (Pijnenborg et al., 1981; Soares et al., 2012). Regulation of deep hemochorial placentation is poorly understood. The rat represents a useful animal model for investigating the regulation of deep hemochorial placentation (Pijnenborg and Vercruysse, 2010; Soares et al., 2012; Shukla and Soares, 2022).
The rat placenta can be divided into two main compartments: the junctional zone and the labyrinth zone (Soares et al., 2012). The junctional zone compartment of the placenta is situated proximal to the uterine endometrium and is responsible for transforming the maternal environment, whereas the labyrinth zone is located between the junctional zone and fetus where it facilitates nutrient delivery to the fetus (Knipp et al., 1999; Soares et al., 2012). Junctional zone-specific functions include the production of peptide and steroid hormones that target maternal organs and the generation of invasive trophoblast cells that migrate into and restructure the uterine parenchyma (Soares et al., 1996; 2012). The extravillous trophoblast cell column is a structure within the human placentation site, which shares some of these same responsibilities (Soares et al., 2018; Knöfler et al., 2019). The junctional zone and extravillous trophoblast cell column are pivotal to the regulation of maternal adaptations to pregnancy, yet little is known about how they are regulated.
Here, we focus on the phosphatidylinositol 3-kinase (PI3K)/AKT pathway and its involvement in regulation of junctional zone biology. AKT1 is one of three AKT serine/threonine kinases and represents an integral component of signal transduction pathways regulating cell proliferation, differentiation, migration, survival and metabolism (Manning and Toker, 2017; Cole et al., 2019). AKT1 has also been implicated in placentation and trophoblast cell development through rodent mutagenesis experiments and investigations with human trophoblast cells (Kamei et al., 2002; Yang et al., 2003; Qiu et al., 2004; Dash et al., 2005; Kent et al., 2010; 2011, 2012; Plaks et al., 2011; Haslinger et al., 2013; Sharma et al., 2016). Disruptions in AKT signaling have been connected to trophoblast cell dysfunction leading to recurrent pregnancy loss, pre-eclampsia and infertility (Pollheimer and Knöfler, 2005; Ferretti et al., 2007; Fisher, 2015; Burton and Jauniaux, 2018). Here, we show that AKT1 inactivation leads to placental and fetal growth restriction in the rat. AKT1 acts via phosphorylation of its target proteins leading to functional changes, including activation or inhibition of target protein function (Manning and Toker, 2017; Cole et al., 2019). We have identified forkhead box O4 (FOXO4), a transcription factor, as an AKT1 substrate within the rat junctional zone and in rat trophoblast cells and demonstrated FOXO4 involvement in junctional zone development and the regulation of trophoblast cell differentiation.
RESULTS
Generation of an Akt1 mutant rat model
AKT1 and phosphorylated AKT are ubiquitously expressed throughout the rat placentation site (Fig. S1A). We examined the role of AKT1 in regulating deep placentation in the rat using CRISPR/Cas9 genome editing. A mutant rat strain possessing a 1332 bp deletion within the Akt1 gene was generated (Fig. 1A,B). The deletion included part of exon 4, the entire region spanning exons 5 and 6, and part of exon 7 and led to a frameshift and premature stop codon (Fig. 1A,B). The deletion effectively removed the kinase domain and regulatory regions of AKT1 (Fig. 1C). The Akt1 mutation was successfully transmitted through the germline. A rat colony possessing the Akt1 mutation was established and maintained via heterozygous×heterozygous breeding. Mating of heterozygotes produced the predicted Mendelian ratio (Fig. 1D; Table S1). Placental tissues possessing a homozygous deletion within the Akt1 locus (Akt1−/−) were deficient in AKT1 protein and exhibited prominent deficits in pan-AKT and phospho-AKT protein expression (Fig. 1E). Residual AKT activity could have arisen from AKT2 or AKT3, as previously demonstrated for rat trophoblast cells (Kent et al., 2011). These findings support the successful disruption of the Akt1 locus and are consistent with AKT1 being the predominant AKT isoform within the placenta (Yang et al., 2003; Kent et al., 2011; Haslinger et al., 2013).
AKT1 deficiency results in placental, fetal and postnatal growth restriction
Disruption of the Akt1 locus in the mouse affects placental, fetal and postnatal growth (Chen et al., 2001; Cho et al., 2001; Yang et al., 2003; Plaks et al., 2011; Kent et al., 2012). We observed a similar phenotype in the rat. Gestation day (gd) 18.5 placental and fetal weights and postnatal pup weights were significantly smaller in the Akt1−/− rat model compared with Akt1+/+ rats (Fig. 2A-H). Junctional and labyrinth zone compartments of the placenta were also significantly smaller in Akt1−/− placentas (Fig. 2D,E,I).
AKT1 regulates junctional zone and invasive trophoblast cell phenotypes
Transcript profiles were determined for Akt1+/+ and Akt1−/− gd 18.5 junctional zone tissues using RNA-sequencing (RNA-seq). The size and morphological phenotypes associated with inactivation of AKT1 were associated with distinct transcript profiles (Fig. 3; Table S2). Disruption of AKT1 resulted in upregulation of 254 transcripts and downregulation of 333 transcripts (Table S2). Pathway analysis included signatures for cell cycle, DNA replication, cellular senescence, and PI3K-AKT signaling pathways (Fig. 3A; Table S3). Transcripts encoding cell cycle progression were consistently repressed in the Akt1−/− junctional zones (Fig. 3A,B). In addition, we also observed prominent downregulation of a member of the expanded prolactin (PRL) gene family, Prl8a4 (2-fold), and the upregulation of cellular communication network factor 3 (3-fold), Ccn3 (also called Nov; Fig. 3B).
The junctional zone serves as the source of invasive trophoblast cells entering the uterus. Consequently, we investigated the uterine-placental interface of Akt1+/+ and Akt1−/− placentas and monitored the surface area occupied by intrauterine invasive trophoblast cells and the expression of invasive trophoblast cell-specific transcripts. Akt1−/− invasive trophoblast cells exhibited decreased infiltration into the uterus (Fig. 3C-E). The decrease in trophoblast invasion was proportional to the size of Akt1+/+ versus Akt1−/− junctional zone compartments (Fig. S1B). We also observed an approximately 50% decrease in the expression of cytokeratin transcripts, which are expressed by invasive trophoblast cells within the uterine-placental interface (Fig. 3F).
Collectively, the data indicate that AKT1 signaling has profound effects on development of the junctional zone and the invasive trophoblast cell lineage.
FOXO4 is a target of PI3K/AKT signaling
Forkhead box (FOX) transcription factors are known targets of PI3K/AKT signaling and have key roles in regulating developmental processes (Lam et al., 2013; Schmitt-Ney, 2020; Herman et al., 2021). We interrogated RNA-seq datasets from the wild-type gd 18.5 junctional zone for FOX family transcription factors. Transcripts for several FOX transcription factors were detected [transcripts per million (TPM) value ≥1.0] (Fig. 4A). Foxo4 transcripts were striking in their abundance relative to all other FOX family members. AKT1 did not significantly affect expression levels for any of the FOX family transcripts (Table S2). Foxo4 transcripts were specifically localized to the junctional zone and a subset of invasive trophoblast cells (Fig. 4B,C). FOXO4 protein and phosphorylated FOXO4 exhibited similar tissue distributions (Fig. S2A). Phosphorylated FOXO4 protein was significantly diminished in Akt1 null junctional zones (Fig. 4D; Fig. S2B). We next explored FOXO4 in differentiated rat trophoblast stem cells (TSCs) (Asanoma et al., 2011). Rat TSCs can differentiate into trophoblast giant cells and spongiotrophoblast cells and represent an effective in vitro model for investigating junctional zone development (Chakraborty et al., 2011, 2016; Asanoma et al., 2012; Kubota et al., 2015; Muto et al., 2021; Varberg et al., 2021). Foxo4 transcript and total and phosphorylated FOXO4 protein showed striking increases in abundance following TSC differentiation (Fig. 4E,F). As previously demonstrated, AKT activity increased following trophoblast cell differentiation (Kamei et al., 2002; Kent et al., 2010, 2011; Fig. 4G). AKT activation was required for optimal FOXO4 phosphorylation (Fig. 4G). Intracellular distributions of FOXO4 and phosphorylated FOXO4 were affected by inhibition of PI3K in differentiated rat TSCs (Fig. 4H). Disruption of PI3K/AKT signaling shifted FOXO4 and phosphorylated FOXO4 to the nucleus (Fig. 4H). Inhibition of PI3K in rat TSCs did not significantly impact a measure of apoptosis (cleaved caspase 3) but did reveal evidence for increased autophagy (Fig. S2C,D). Thus, we provide support for a link between PI3K/AKT signaling and FOXO4 in trophoblast cell lineage development.
Generation of a Foxo4 mutant rat model
We examined the role of FOXO4 in regulating placentation in the rat using CRISPR/Cas9 genome editing. The Foxo4 gene consists of four exons and resides on the X chromosome (Liu et al., 2020). A mutant rat strain possessing a 3096 bp deletion within the Foxo4 gene was generated (Fig. 5A,B). The deletion included the 3′ part of exon 2 and the 5′ part of exon 3 and led to a frameshift and a premature stop codon (Fig. 5A,B). The deletion effectively disrupted the conserved forkhead DNA-binding domain and removed nuclear localization, nuclear export, and transactivation domains of FOXO4 (Fig. 5C). The Foxo4 mutation was successfully transmitted through the germline (Fig. 5D; Table S4). A rat colony possessing the Foxo4 mutation was established and maintained via hemizygous male×wild-type female breeding, which produced the predicted Mendelian ratio (Table S4). Junctional zone tissues possessing a maternally inherited Foxo4 mutation (Foxo4Xm−) were deficient in FOXO4 protein (Fig. 5E). The results are consistent with paternal silencing of X chromosome-linked genes expressed in extra-embryonic tissues (Takagi and Sasaki, 1975; West et al., 1978; Hemberger, 2002). FOXO4 was successfully disrupted in the rat.
FOXO4 deficiency results in placentomegaly and a modified junctional zone phenotype
Placentation site phenotypes of mice possessing mutations at the Foxo4 locus have not been described (Hosaka et al., 2004). Rats possessing a maternally inherited mutant Foxo4 allele (Foxo4Xm−) exhibited placentomegaly and decreased placental efficiency (fetal/placental weight ratio) when examined on gd 18.5 (Fig. 6A-C) and gd 20.5 (Fig. S3A-C). In contrast, a paternally inherited mutant Foxo4 allele did not significantly affect placental or fetal weights (Fig. S3D,E). FOXO4 deficiency-associated placentomegaly included significantly larger junctional and labyrinth zones (Fig. 6D-G; Fig. S3F-H), but did not affect the intrauterine invasive trophoblast cell lineage (Fig. S4). Transcript profiles were determined for wild-type (Foxo4Xm+) and Foxo4Xm− gd 18.5 junctional zone tissues by RNA-seq (Fig. 6H). Disruption of FOXO4 resulted in upregulation of 369 transcripts and downregulation of 845 transcripts (Table S5). Pathway analysis included signatures for PI3K-AKT signaling, cell cycle, DNA replication, extracellular matrix receptor interaction, and complement and coagulation pathways (Fig. 6H; Table S6). Cell cycle and DNA replication signatures may be contributing to the size disparities in wild-type (Foxo4Xm+) versus Foxo4Xm− junctional zone compartments. Junctional adhesion molecule-like (JAML), lipoprotein(a) like 2 (LPAL2), erb-b2 receptor tyrosine kinase 3 (ERBB3), and growth factor receptor bound protein 7 (GRB7) were each conspicuous in their prominent downregulation (>90% decrease) in FOXO4-deficient junctional zone tissue (Fig. 6I). JAML contributes to epithelial barrier function, modulates immune cell trafficking, and regulates angiogenesis (Kummer and Ebnet, 2018), whereas LPAL2 is a long noncoding RNA contributing to inflammatory and oxidative stress responses (Han et al., 2018). JAML and LPAL2 have not previously been linked to trophoblast or placental biology. ERBB3 is a receptor for neuregulin 1 and promotes trophoblast cell survival (Fock et al., 2015) and GRB7 is an adaptor protein participating in signal transduction activated through ERBB3 (Fiddes et al., 1998). Interestingly, numerous junctional zone transcripts regulated by FOXO4 were reciprocally regulated by AKT1 (88% of transcripts upregulated in Akt1 null were downregulated in Foxo4 mutant tissues; 38% of transcripts downregulated in Akt1 null were upregulated in Foxo4 mutant tissues; Fig. 7). The reciprocal relationship between AKT1 and FOXO4 is evident at structural and molecular levels.
FOXO4 contributes to the regulation of the trophoblast cell lineage
We next modeled junctional zone cell biology using rat TSCs. The consequences of FOXO4 disruption in differentiating rat TSCs were examined. FOXO4 expression was inhibited via ectopic expression of short hairpin RNAs specific to Foxo4 (Fig. 8A,B). Although a morphologic phenotype was not evident, prominent differences in the transcriptomes of TSCs expressing control versus Foxo4 shRNAs were observed (Fig. 8C). Disruption of FOXO4 resulted in upregulation of 260 transcripts and downregulation of 443 transcripts (Table S7). Pathway analysis included signatures for PI3K-AKT signaling, longevity regulating, calcium signaling, and glutathione metabolism pathways (Fig. 8C; Table S8). Among the dysregulated transcripts was an upregulation of matrix metallopeptidase 12 (2-fold), a known constituent of endovascular invasive trophoblast cells (Harris et al., 2010; Chakraborty et al., 2016), and downregulation of trophoblast specific protein alpha (3-fold), a transcript characteristic of spongiotrophoblast cells within the junctional zone (Iwatsuki et al., 2000). FOXO4 is a known regulator of responses to oxidative stress (Liu et al., 2020). Several transcripts associated with inflammatory and cellular stress responses (Sies and Cadenas, 1985; LaFleur et al., 2001; Mashima and Okuyama, 2015; Han et al., 2018; Huang et al., 2021; Nirgude and Choudhary, 2021; Qayyum et al., 2021; Satapathy and Wilson, 2021), including thioredoxin interacting protein (7-fold), glutathoione S-transferase mu 1 (3-fold), arachidonate 5-lipoxygenase activating protein (2-fold), interferon kappa (10-fold), nuclear protein 1 (2.7-fold) and Lpal2 (2.2-fold), were prominently downregulated.
In vivo and in vitro disruptions of FOXO4 were consequential, but did not yield identical transcriptomic effects. These discrepancies may reflect intrinsic differences in the cellular compositions of the gd 18.5 junctional zone versus differentiated rat TSCs, in vivo versus in vitro cell environments, or the null in vivo model versus the hypomorphic in vitro model.
Key findings
Collectively, the results indicate that AKT1 drives placental growth, including regulation of deep intrauterine trophoblast cell invasion. These actions are accomplished, at least in part, through modulation of FOXO4, which acts to restrain placental growth and coordinate responses to physiological stressors.
DISCUSSION
The rat and human possess a type of hemochorial placentation whereby specialized trophoblast cells penetrate deep into the uterus and transform the uterine parenchyma, including the vasculature (Pijnenborg et al., 1981; Pijnenborg and Vercruysse, 2010; Soares et al., 2012). Central to deep placentation is the source of invasive trophoblast cells, which is a compartment within the placenta referred as the junctional zone in rat and the extravillous trophoblast cell column in human (Soares et al., 2012, 2018; Knöfler et al., 2019). In addition to an intrauterine role, the cellular constituents of these placental compartments produce hormones directed to maternal tissues with actions that ensure in utero survival and promotion of fetal growth (Soares et al., 1996; John, 2017). In this study, AKT1 and FOXO4 were identified as regulators of rat junctional zone development. In vivo disruption of AKT1 and FOXO4 led to opposite effects on junctional zone development. AKT1 deficiency resulted in growth restriction of the junctional zone, phenotypic alteration of the invasive trophoblast cell lineage, as well as compromised fetal and postnatal growth, and AKT1 was capable of phosphorylating FOXO4 in rat trophoblast cells. Deficiency of FOXO4 resulted in an expanded junctional zone. Deficits in AKT1 or FOXO4 also impacted transcriptomic profiles of the junctional zone. The findings indicate that AKT1 and FOXO4 are part of a gene regulatory network controlling hemochorial placentation.
AKT1 signaling influenced placental development. Akt1 null mutations in the mouse and rat yield similar phenotypes characterized by placental, fetal and postnatal growth restriction (Chen et al., 2001; Cho et al., 2001; Yang et al., 2003; Plaks et al., 2011; Kent et al., 2012). Smaller junctional zones accompanying AKT1 deficiency were associated with a downregulation of transcripts encoding proteins driving cell proliferation. These results imply that size differences of junctional zone compartments in the wild type versus Akt1 nulls were related to, at least in part, diminished trophoblast cell proliferation in Akt1 junctional zone tissues. The data also fit well with known actions of AKT signaling promoting cell proliferation in a wide range of cell types (Manning and Cantley, 2007; Manning and Toker, 2017; Cole et al., 2019). AKT1 disruption also altered differentiated junctional zone trophoblast cell phenotypes. As cellular constituents of the junctional zone differentiate, they acquire the capacity to express several members of the expanded PRL family of hormones/cytokines (Soares, 2004; Alam et al., 2006; Soares et al., 2007). The expression of PRL8A4, a member of the expanded PRL family, was downregulated in Akt1 null junctional zones. PRL8A4 is an orphan ligand with little known of its significance to the biology of pregnancy other than as a signature feature of the differentiated junctional zone phenotype (Iwatsuki et al., 1998; Soares et al., 2007). AKT signaling has previously been implicated in the regulation of rodent and human trophoblast cell differentiation (Kamei et al., 2002; Kent et al., 2010, 2011; Haslinger et al., 2013). Disruption of Akt1 also interfered with invasive trophoblast cell development. Trophoblast cell infiltration into the uterine-placental interface was diminished in Akt1 nulls. Involvement of AKT signaling has also been implicated in the development of the human extravillous trophoblast cell lineage (Pollheimer and Knöfler, 2005; Haslinger et al., 2013; Morey et al., 2021). AKT signaling could affect invasive trophoblast cell development through its actions on their origin in the junctional zone and extravillous trophoblast cell column or, alternatively, their maturation as they invade into the uterus. Finally, the impact of AKT signaling in invasive trophoblast cell development may be more profound than observed with AKT1 deficiency owing to compensatory activities of AKT2 and AKT3 (Kent et al., 2011; Haslinger et al., 2013).
AKT1 regulates cellular function through its actions as a serine/threonine kinase and, thus, phosphorylation of its substrates (Manning and Cantley, 2007; Manning and Toker, 2017; Cole et al., 2019). The FOX family of transcription factors are well-established targets of AKT action (Lam et al., 2013; Schmitt-Ney, 2020; Herman et al., 2021). Among FOX family members, FOXO4 expression was uniquely elevated in the rat junctional zone. FOXO4 phosphorylation state in trophoblast cells was affected by AKT signaling. AKT-mediated phosphorylation of FOXO4 leads to FOXO4 exit from the nucleus and inactivation (Schmitt-Ney, 2020; Herman et al., 2021), which might suggest that an AKT1 deficiency would result in the stabilization of FOXO4 protein in the junctional zone. Instead, AKT1 deficiency led to depletion of junctional zone total and phosphorylated FOXO4 proteins. Consequently, the observed Akt1 null placental phenotype was associated with the depletion of both AKT1 and FOXO4 proteins. In addition to regulation by AKT signaling, FOXO4 activity/stability is stimulated by Jun kinase and monoubiquitylation (Essers et al., 2004; van der Horst et al., 2006; Brenkman et al., 2008; Liu et al., 2020), and inhibited by acetylation and polyubiquitylation (Fukuoka et al., 2003; Huang and Tindall, 2011; Liu et al., 2020). Whether AKT1 indirectly affects FOXO4 protein by impacting these other FOXO4 regulators remains to be determined.
FOXO4 is a transcription factor implicated in the regulation of the cell cycle, apoptosis, responses to oxidative stress, and a range of disease processes (Liu et al., 2020). The original characterization of the Foxo4 null mouse concluded that FOXO4 did not have a singular role in the pathophysiology of the mouse (Hosaka et al., 2004). The absence of a reported phenotype for the Foxo4 null mouse model was attributed to the compensatory actions of other members of the FOXO family, including FOXO1, FOXO3, and possibly FOXO6 (Hosaka et al., 2004; Liu et al., 2020). We describe a prominent placental phenotype for the Foxo4 null rat model. The placental anomalies associated with FOXO4 deficiency were compatible with the production of viable offspring. The absence of a fertility defect in the Foxo4 null mouse model likely precluded a closer examination of placentation (Hosaka et al., 2004). However, it is also possible that elements of FOXO4 action are species specific. FOXO4 is prominently expressed in the junctional zone and to a lesser extent in invasive trophoblast cells. Disruption of FOXO4 led to an expansion of both junctional and labyrinth zone placental compartments, which probably reflects cell-autonomous and non-cell-autonomous actions, respectively. A striking reciprocal pattern of AKT1 versus FOXO4 gene regulation within the junctional zone was demonstrated and included differentially regulated transcripts encoding proteins involved in the regulation of cell proliferation and cell death. We surmise that AKT1 promotes junctional zone growth by stimulating the expression of transcripts connected to cell cycle progression and inhibiting transcripts connected to cell death, whereas the converse is true for FOXO4. These biological roles are consistent with the known actions of AKT1 and FOXO4 in other cell systems (Manning and Toker, 2017; Liu et al., 2020; Herman et al., 2021). A transcriptional regulatory network involving FOXO4 has also been identified in human extravillous trophoblast cells (Morey et al., 2021). Importantly, FOXO4 also regulates trophoblast cell responses to oxidative stress and is thus positioned to contribute to placental adaptations to a compromised maternal environment and in disease states affecting placentation.
MATERIALS AND METHODS
Animals
Holtzman Sprague-Dawley rats were maintained in an environmentally controlled facility with lights on from 06:00 to 20:00 h with food and water available ad libitum. Time-mated pregnancies were established by co-housing adult female rats (8-10 weeks of age) with adult male rats (>10 weeks of age). Detection of sperm or a seminal plug in the vagina was designated gd 0.5. Pseudopregnant females were generated by co-housing adult female rats (8-10 weeks of age) with adult male vasectomized males (>10 weeks of age). The detection of seminal plugs was designated pseudopregnancy day 0.5. Four- to five-week-old donor rats were superovulated by intraperitoneal injection of pregnant mare serum gonadotropin (30 units, G4877, Sigma-Aldrich), followed by an intraperitoneal injection of human chorionic gonadotropin (30 units, C1063, Sigma-Aldrich) ∼46 h later, and immediately mated with adult males. Zygotes were flushed from oviducts the next morning (gd 0.5). The University of Kansas Medical Center (KUMC) Animal Care and Use Committee approved all protocols involving the use of rats.
Tissue collection and analysis
Rats were euthanized by CO2 asphyxiation at designated days of gestation. Uterine segments containing placentation sites were frozen in dry ice-cooled heptane and stored at −80°C until processed for histological analyses. Alternatively, placentation sites were dissected into placentas, the adjacent uterine-placental interface tissue (also referred to as the metrial gland), and fetuses as previously described (Ain et al., 2006). Placentas were weighed and dissected into junctional zone and labyrinth zone compartments (Ain et al., 2006). Placental compartments and uterine-placental interfaces were frozen in liquid nitrogen and stored at −80°C until used for biochemical analyses. Fetuses were weighed, genotyped, and sex determined by PCR (Dhakal and Soares, 2017).
Generation of Akt1 and Foxo4 mutant rat models
Mutations at Akt1 and Foxo4 loci were generated using CRISPR/Cas9 genome editing (Kaneko, 2017; Iqbal et al., 2021). Guide RNAs targeting exon 4 (target sequence: GCCGTTTGAGTCCATCAGCC; nucleotides 356-375) and exon 7 (target sequence: TTGTCATGGAGTACGCCAAT; nucleotides 712-731) of the Akt1 gene (NM_033230.3) or targeting exon 2 (target sequence: CCAGATATACGAATGGATGGTCC; nucleotides 517-539) and exon 3 (target sequence: GTTCATCAAGGTACATAACGAGG; nucleotides 631-653) of the Foxo4 gene (NM_001106943.1) were electroporated into single-cell rat embryos using the NEPA21 electroporator (Nepa Gene Co Ltd). Electroporated embryos were transferred to oviducts of day 0.5 pseudopregnant rats. Initially, offspring were screened for Akt1 or Foxo4 mutations from genomic DNA from tail-tip biopsies using the REDExtract-N-AmpTM Tissue PCR kit (XNAT, Millipore Sigma). PCR was performed on the purified DNA samples using primers flanking the guide RNA sites, and products resolved by agarose gel electrophoresis and ethidium bromide staining. Genomic DNA containing potential mutations was amplified by PCR, gel-purified, and precise boundaries of deletions determined by DNA sequencing (Genewiz Inc.). Founders with Akt1 or Foxo4 mutations were backcrossed to wild-type rats to demonstrate germline transmission. Routine genotyping was performed by PCR on genomic DNA with specific sets of primers (Table S9).
Western blot analysis
Tissue lysates were prepared using the radioimmunoprecipitation assay lysis buffer system (sc-24948A, Santa Cruz Biotechnology). Protein concentrations were determined using the DCTM Protein Assay Kit (5000112, Bio-Rad Laboratories). Proteins (20 µg/lane) were separated by SDS-PAGE. Separated proteins were electrophoretically transferred to polyvinylidene difluoride membranes (10600023, GE Healthcare) for 1 h at 100 V on ice. Membranes were subsequently blocked with 5% milk or 5% bovine serum albumin for 1 h at room temperature and probed separately with specific primary antibodies to AKT1 (1:1000, 75692, Cell Signaling Technology), pan-AKT (1:1000, 4691, Cell Signaling Technology), phospho-Ser473 AKT (1:2000, 4060, Cell Signaling Technology), FOXO4 (1:2000, 21535-1-AP, Proteintech), phospho-Ser262 FOXO4 (1:3000, ab126594, Abcam), cleaved caspase-3 (Asp175, 1:1000, 9664, Cell Signaling Technology), serine palmitoyltransferase long chain base subunit 3 (LC3B, 1:1000, 2775, Cell Signaling Technology) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH, 1:5000, ab8245, Abcam) in Tris-buffered saline with 0.1% Tween 20 (TBST) overnight at 4°C. After primary antibody incubation, the membranes were washed in TBST three times (10 min each wash) at room temperature. After washing, the membranes were incubated with anti-rabbit or anti-mouse IgG conjugated to horseradish peroxidase [HRP; 1:5000 or 1:20,000 (phospho-Ser262 FOXO4), 7074S and 7076S, Cell Signaling Technology] in TBST for 1 h at room temperature, washed in TBST three times (10 min each wash) at room temperature, immersed in Immobilon Crescendo Western HRP Substrate (WBLUR0500, Sigma-Aldrich), and luminescence detected using Radiomat LS film (Agfa Healthcare) or a Chemi Doc MP Imager (Bio-Rad).
Transcript analysis
Total RNA was extracted from tissues using TRI Reagent Solution (AM9738, Thermo Fisher Scientific) according to the manufacturer's instructions. Total RNA (1 µg) was reverse transcribed using a High-Capacity cDNA Reverse Transcription Kit (4368813, Thermo Fisher Scientific). Complementary DNAs were diluted 1:10 and subjected to reverse transcription-quantitative PCR (RT-qPCR) using PowerUp SYBR Green Master Mix (A25742, Thermo Fisher Scientific) and the primers provided in Table S10. QuantStudio 5 Flex Real-Time PCR System (Applied Biosystems) was used for amplification and fluorescence detection. PCR was performed under the following conditions: 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. Relative mRNA expression was calculated using the delta-delta Ct method. Gapdh was used as a reference transcript.
RNA-seq analysis
Transcript profiles were generated from wild-type and Akt1−/−, and Foxo4Xm− junctional zone tissues, and rat differentiated TSCs expressing control or Foxo4 shRNAs. Complementary DNA libraries from total RNA samples were prepared using Illumina TruSeq RNA preparation kits according to the manufacturer's instructions (Illumina). RNA integrity was assessed using an Agilent 2100 Bioanalyzer. Barcoded cDNA libraries were multiplexed onto a TruSeq paired-end flow cell and sequenced (100-bp paired-end reads) with a TruSeq 200-cycle SBS kit (Illumina). Samples were run on an Illumina NovaSeq 6000 sequencer at the KUMC Genome Sequencing Facility. Reads from *.fastq files were mapped to the rat reference genome (Ensembl Rnor_5.0.78) using CLC Genomics Workbench 12.0 (QIAGEN). Transcript abundance was expressed as TPM and a P-value of 0.05 was used as a cutoff for significant differential expression. Statistical significance was calculated by empirical analysis of digital gene expression followed by Bonferroni's correction. Pathway analysis was performed using Database for Annotation, Visualization, and Integrated Discovery (DAVID; Huang et al., 2009).
Immunohistochemistry
Placentation sites were embedded in optimum cutting temperature (OCT) compound and sectioned at 10 µm thickness using a Leica CM1850 cryostat. Sections were fixed in 4% paraformaldehyde, washed in PBS (pH 7.4) three times (5 min each wash), blocked with 10% normal goat serum (50062Z, Thermo Fisher Scientific), and incubated overnight with primary antibodies: pan cytokeratin (1:300, F3418, Sigma-Aldrich) to identify trophoblast cells; vimentin (1:300, sc-6260, Santa Cruz Biotechnology) to distinguish placental compartments; FOXO4 (1:300, 21535-1-AP, Proteintech); and phospho-Ser262 FOXO4 (1:300, ab126594, Abcam). After washing with PBS (pH 7.4), sections were incubated with corresponding secondary antibodies: Alexa 568-conjugated goat anti-rabbit IgG (1:500, A11011, Thermo Fisher Scientific) or Alexa 568-conjugated rabbit anti-mouse IgG (1:500, A9044, Sigma-Aldrich) for 2 h at room temperature. Sections were then stained with DAPI (1/25,000, D1306, Invitrogen) and mounted using Fluoromount-G mounting media (0100-01, Southern Biotech) and examined microscopically. Fluorescence images were captured on a Nikon 90i upright microscope with a Photometrics CoolSNAP-ES monochrome camera (Roper). The area occupied by cytokeratin-positive cells (invasive trophoblast cells) within the uterine-placental interface was quantified using ImageJ software, as previously described (Nteeba et al., 2020).
In situ hybridization
Distributions of transcripts for Foxo4 and Prl7b1 were determined on cryosections of rat placentation sites. RNAScope Multiplex Fluorescent Reagent Kit version 2 (Advanced Cell Diagnostics) was used for in situ hybridization analysis. Probes were prepared to detect Foxo4 (NM_001106943.1, 1038981-C1, target region: 750-1651) and Prl7b1 (NM_153738.1, 860181-C2, target region: 28-900). Fluorescence images were captured on a Nikon 80i upright microscope with a Photometrics CoolSNAP-ES monochrome camera (Roper).
Rat TSC culture
Blastocyst-derived rat TSCs (Asanoma et al., 2011) were cultured in Rat TS Cell Medium [RPMI 1640 medium (11875093, Thermo Fisher Scientific), 20% (vol/vol) fetal bovine serum (FBS; Thermo Fisher Scientific), 100 µM 2-mercaptoethanol (M7522, Sigma-Aldrich), 1 mM sodium pyruvate (11360-070, Thermo Fisher Scientific), 100 µM penicillin and 50 U/ml streptomycin (15140122, Thermo Fisher Scientific)] supplemented with 70% rat embryonic fibroblast-conditioned medium prepared as described previously (Asanoma et al., 2011), 25 ng/ml fibroblast growth factor 4 (FGF4; 100-31, Peprotech) and 1 µg/ml heparin (H3149, Sigma-Aldrich). For induction of differentiation, rat TSCs were cultured for 15 days in rat TS medium containing 1% (vol/vol) FBS without FGF4, heparin, and rat embryonic fibroblast-conditioned medium. In some experiments, rat TSCs were exposed to a PI3K inhibitor (LY294002, 10 μM, 9901, Cell Signaling Technology), chloroquine (50 μM for 24 h, C6628, Sigma-Aldrich) or staurosporine (1 μM for 3 h, 9953, Cell Signaling Technology) followed by western blot analysis or immunohistochemistry.
Lentivirus construction and production
Lentivirus construction and production were described previously (Muto et al., 2021; Varberg et al., 2021). Briefly, the lentivirus encoding the shRNA targeting Foxo4 was constructed using a pLKO.1 vector. shRNA oligo sequences used in the analyses are provided in Table S11. Lentiviral packaging vectors were obtained from Addgene and included pMDLg/pRRE (plasmid #12251), pRSV-Rev (plasmid #12253), pMD2.G (plasmid #12259). Lentiviral particles were produced using Attractene (301005, QIAGEN) in human embryonic kidney (HEK) 293FT cells (Thermo Fisher Scientific).
Lentiviral transduction
Rat TSCs were incubated with lentiviral particles for 24 h followed by selection with puromycin dihydrochloride (5 µg/ml; A11138-03, Thermo Fisher Scientific) for 2 days. Cells were then cultured for 1-3 days in Rat TS Cell Medium prior to differentiation.
Statistical analysis
Student's t-test, Welch's t-test, Dunnett's test or Steel test were performed, where appropriate, to evaluate the significance of the experimental manipulations. Results were deemed statistically significant when P<0.05.
Acknowledgements
We thank Stacy Oxley and Brandi Miller for administrative assistance and the KUMC Genome Sequencing Facility for assistance with RNA-seq, including library preparation and sequencing.
Footnotes
Author contributions
Conceptualization: K.K., A.M.-I., M.J.S.; Methodology: A.M.-I., M.-L.W., R.L.S., M.E.S., M.M.; Validation: K.K., A.M.-I., R.L.S., M.E.S., M.M.; Formal analysis: K.K., A.M.-I., K.I., M.J.S.; Investigation: K.K., A.M.-I., K.I., M.-L.W., R.L.S., M.E.S., M.M.; Resources: M.R.P., M.J.S.; Data curation: K.I.; Writing - original draft: K.K., A.M.-I., M.J.S.; Writing - review & editing: K.K., A.M.-I., K.I., M.-L.W., R.L.S., M.E.S., M.M., M.R.P., M.J.S.; Visualization: K.K., A.M.-I.; Supervision: M.J.S.; Project administration: M.J.S.; Funding acquisition: M.J.S.
Funding
This research was supported by postdoctoral fellowships from the Kansas IDeA Network of Biomedical Research Excellence (P20 GM103418 to A.M-I.), the Lalor Foundation (K.K., A.M-I., M.M.), the American Heart Association (K.K., M.M.), a National Institutes of Health (NIH) National Research Service Award (HD104495 to R.L.S.) and NIH grants (HD020676, HD079363, HD099638, HD105734), and the Sosland Foundation. Deposited in PMC for release after 12 months.
Data availability
RNA-seq datasets are available at the Gene Expression Omnibus database under accession number GSE205831.
References
Competing interests
The authors declare no competing or financial interests.